Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Enduring changes in brain metabolites and executive functioning in abstinent cocaine users.

Crocker CE, Purdon SE, Hanstock CC, Lakusta B, Seres P, Tibbo PG.

Drug Alcohol Depend. 2017 Sep 1;178:435-442. doi: 10.1016/j.drugalcdep.2017.04.034. Epub 2017 Jun 28.

PMID:
28710968
2.

Diffusion-weighted J-resolved spectroscopy.

Landheer K, Schulte R, Geraghty B, Hanstock C, Chen AP, Cunningham CH, Graham SJ.

Magn Reson Med. 2017 Oct;78(4):1235-1245. doi: 10.1002/mrm.26514. Epub 2016 Oct 31.

PMID:
27797114
3.

Illness versus substance use effects on the frontal white matter in early phase schizophrenia: A 4Tesla (1)H-MRS study.

Bernier D, Bartha R, McAllindon D, Hanstock CC, Marchand Y, Dillen KNH, Gallant M, Good KP, Tibbo PG.

Schizophr Res. 2016 Aug;175(1-3):4-11. doi: 10.1016/j.schres.2016.04.022. Epub 2016 May 6.

PMID:
27161760
4.

Fatigue in Multiple Sclerosis: Assessing Pontine Involvement Using Proton MR Spectroscopic Imaging.

Zaini WH, Giuliani F, Beaulieu C, Kalra S, Hanstock C.

PLoS One. 2016 Feb 19;11(2):e0149622. doi: 10.1371/journal.pone.0149622. eCollection 2016.

5.

Prefrontal glutamate levels differentiate early phase schizophrenia and methamphetamine addiction: a (1)H MRS study at 3Tesla.

Crocker CE, Bernier DC, Hanstock CC, Lakusta B, Purdon SE, Seres P, Tibbo PG.

Schizophr Res. 2014 Aug;157(1-3):231-7. doi: 10.1016/j.schres.2014.05.004. Epub 2014 Jun 3.

PMID:
24906219
6.

NPAS3 variants in schizophrenia: a neuroimaging study.

Bernier D, Macintyre G, Bartha R, Hanstock CC, McAllindon D, Cox D, Purdon S, Aitchison KJ, Rusak B, Tibbo PG.

BMC Med Genet. 2014 Mar 27;15:37. doi: 10.1186/1471-2350-15-37.

7.

Multimodal neuroimaging of frontal white matter microstructure in early phase schizophrenia: the impact of early adolescent cannabis use.

Bernier D, Cookey J, McAllindon D, Bartha R, Hanstock CC, Newman AJ, Stewart SH, Tibbo PG.

BMC Psychiatry. 2013 Oct 17;13:264. doi: 10.1186/1471-244X-13-264.

8.

Increased glutamate levels in the medial prefrontal cortex in patients with postpartum depression.

McEwen AM, Burgess DT, Hanstock CC, Seres P, Khalili P, Newman SC, Baker GB, Mitchell ND, Khudabux-Der J, Allen PS, LeMelledo JM.

Neuropsychopharmacology. 2012 Oct;37(11):2428-35. doi: 10.1038/npp.2012.101. Epub 2012 Jul 18.

9.

3-T proton magnetic spectroscopy in unmedicated first episode psychosis: a focus on creatine.

Tibbo PG, Bernier D, Hanstock CC, Seres P, Lakusta B, Purdon SE.

Magn Reson Med. 2013 Mar 1;69(3):613-20. doi: 10.1002/mrm.24291. Epub 2012 Apr 17.

10.

Ventricular dilatation and brain atrophy in patients with Parkinson's disease with incipient dementia.

Camicioli R, Sabino J, Gee M, Bouchard T, Fisher N, Hanstock C, Emery D, Martin WR.

Mov Disord. 2011 Jul;26(8):1443-50. doi: 10.1002/mds.23700. Epub 2011 Mar 25.

PMID:
21442661
11.

Degeneration of the mid-cingulate cortex in amyotrophic lateral sclerosis detected in vivo with MR spectroscopy.

Sudharshan N, Hanstock C, Hui B, Pyra T, Johnston W, Kalra S.

AJNR Am J Neuroradiol. 2011 Feb;32(2):403-7. doi: 10.3174/ajnr.A2289. Epub 2010 Nov 18.

12.

Considerations for measuring the fractional anisotropy of metabolites with diffusion tensor spectroscopy.

Ellegood J, Hanstock CC, Beaulieu C.

NMR Biomed. 2011 Apr;24(3):270-80. doi: 10.1002/nbm.1586. Epub 2010 Oct 6.

PMID:
20925126
13.

Spectral editing of weakly coupled spins using variable flip angles in PRESS constant echo time difference spectroscopy: application to GABA.

Snyder J, Hanstock CC, Wilman AH.

J Magn Reson. 2009 Oct;200(2):245-50. doi: 10.1016/j.jmr.2009.07.010. Epub 2009 Aug 3.

PMID:
19648038
14.

Combined structural and neurochemical evaluation of the corticospinal tract in amyotrophic lateral sclerosis.

Pyra T, Hui B, Hanstock C, Concha L, Wong JC, Beaulieu C, Johnston W, Kalra S.

Amyotroph Lateral Scler. 2010;11(1-2):157-65. doi: 10.3109/17482960902756473.

PMID:
19242831
15.

Motor cortex and spinal degeneration in multisystem atrophy: a multimodal study.

Muayqil T, Chan KM, Camicioli R, Hanstock C, Wong J, Concha L, Beaulieu C, Johnston W, Stenerson P, Kalra S.

Can J Neurol Sci. 2008 Nov;35(5):658-60. No abstract available.

PMID:
19235454
16.

Intact presupplementary motor area function in early, untreated Parkinson's disease.

Martin WR, Wieler M, Gee M, Hanstock CC, Camicioli RM.

Mov Disord. 2008 Sep 15;23(12):1756-9. doi: 10.1002/mds.22101.

PMID:
18709678
17.

Voxel-based morphometry reveals extra-nigral atrophy patterns associated with dopamine refractory cognitive and motor impairment in parkinsonism.

Camicioli R, Gee M, Bouchard TP, Fisher NJ, Hanstock CC, Emery DJ, Martin WR.

Parkinsonism Relat Disord. 2009 Mar;15(3):187-95. doi: 10.1016/j.parkreldis.2008.05.002. Epub 2008 Jun 24.

PMID:
18573676
18.

Acute dextro-amphetamine administration does not alter brain myo-inositol levels in humans and animals: MRS investigations at 3 and 18.8 T.

McGrath BM, McKay R, Dave S, Seres P, Weljie AM, Slupsky CM, Hanstock CC, Greenshaw AJ, Silverstone PH.

Neurosci Res. 2008 Aug;61(4):351-9. doi: 10.1016/j.neures.2008.04.001. Epub 2008 Apr 18.

PMID:
18508145
19.

Elevated 3T proton MRS glutamate levels associated with poor Continuous Performance Test (CPT-0X) scores and genetic risk for schizophrenia.

Purdon SE, Valiakalayil A, Hanstock CC, Seres P, Tibbo P.

Schizophr Res. 2008 Feb;99(1-3):218-24. doi: 10.1016/j.schres.2007.11.028. Epub 2008 Jan 14.

PMID:
18248960
20.

Proton magnetic resonance spectroscopy measurement of brain glutamate levels in premenstrual dysphoric disorder.

Batra NA, Seres-Mailo J, Hanstock C, Seres P, Khudabux J, Bellavance F, Baker G, Allen P, Tibbo P, Hui E, Le Melledo JM.

Biol Psychiatry. 2008 Jun 15;63(12):1178-84. Epub 2007 Dec 3.

PMID:
18061146
21.

Is brain lactate increased in Huntington's disease?

Martin WR, Wieler M, Hanstock CC.

J Neurol Sci. 2007 Dec 15;263(1-2):70-4. Epub 2007 Jul 25.

PMID:
17655868
22.

Age and dementia-associated atrophy predominates in the hippocampal head and amygdala in Parkinson's disease.

Bouchard TP, Malykhin N, Martin WR, Hanstock CC, Emery DJ, Fisher NJ, Camicioli RM.

Neurobiol Aging. 2008 Jul;29(7):1027-39. Epub 2007 Mar 26.

PMID:
17368653
23.

Magnetic resonance spectroscopic evidence for presupplementary motor area neuronal dysfunction in Parkinson's disease.

Camicioli RM, Hanstock CC, Bouchard TP, Gee M, Fisher NJ, Martin WR.

Mov Disord. 2007 Feb 15;22(3):382-6.

PMID:
17216652
24.

The relation between peripheral and central glutamate and glutamine in healthy male volunteers.

Shulman Y, Grant S, Seres P, Hanstock C, Baker G, Tibbo P.

J Psychiatry Neurosci. 2006 Nov;31(6):406-10.

25.

Anisotropic diffusion of metabolites in peripheral nerve using diffusion weighted magnetic resonance spectroscopy at ultra-high field.

Ellegood J, McKay RT, Hanstock CC, Beaulieu C.

J Magn Reson. 2007 Jan;184(1):20-8. Epub 2006 Oct 5.

PMID:
17027305
26.

Detection of cerebral degeneration in amyotrophic lateral sclerosis using high-field magnetic resonance spectroscopy.

Kalra S, Hanstock CC, Martin WR, Allen PS, Johnston WS.

Arch Neurol. 2006 Aug;63(8):1144-8.

PMID:
16908742
27.

Diffusion tensor spectroscopy (DTS) of human brain.

Ellegood J, Hanstock CC, Beaulieu C.

Magn Reson Med. 2006 Jan;55(1):1-8.

28.

Brain gamma-aminobutyric acid measurement by proton double-quantum filtering with selective J rewinding.

Choi C, Coupland NJ, Hanstock CC, Ogilvie CJ, Higgins AC, Gheorghiu D, Allen PS.

Magn Reson Med. 2005 Aug;54(2):272-9.

29.

Decreased prefrontal Myo-inositol in major depressive disorder.

Coupland NJ, Ogilvie CJ, Hegadoren KM, Seres P, Hanstock CC, Allen PS.

Biol Psychiatry. 2005 Jun 15;57(12):1526-34.

PMID:
15953489
30.
31.

Variability of metabolite yield using STEAM or PRESS sequences in vivo at 3.0 T, illustrated with myo-inositol.

Kim H, Thompson RB, Hanstock CC, Allen PS.

Magn Reson Med. 2005 Apr;53(4):760-9.

32.

Brain choline concentrations may not be altered in euthymic bipolar disorder patients chronically treated with either lithium or sodium valproate.

Wu RH, O'Donnell T, Ulrich M, Asghar SJ, Hanstock CC, Silverstone PH.

Ann Gen Hosp Psychiatry. 2004 Jul 30;3(1):13.

33.

3-T proton MRS investigation of glutamate and glutamine in adolescents at high genetic risk for schizophrenia.

Tibbo P, Hanstock C, Valiakalayil A, Allen P.

Am J Psychiatry. 2004 Jun;161(6):1116-8.

PMID:
15169703
34.

Lithium and valproate protect against dextro-amphetamine induced brain choline concentration changes in bipolar disorder patients.

Silverstone PH, Asghar SJ, O'Donnell T, Ulrich M, Hanstock CC.

World J Biol Psychiatry. 2004 Jan;5(1):38-44. Review.

PMID:
15048634
35.

Posterior cingulate metabolic changes occur in Parkinson's disease patients without dementia.

Camicioli RM, Korzan JR, Foster SL, Fisher NJ, Emery DJ, Bastos AC, Hanstock CC.

Neurosci Lett. 2004 Jan 16;354(3):177-80.

PMID:
14700725
36.

Effects of chronic lithium and sodium valproate on concentrations of brain amino acids.

O'Donnell T, Rotzinger S, Ulrich M, Hanstock CC, Nakashima TT, Silverstone PH.

Eur Neuropsychopharmacol. 2003 Aug;13(4):220-7.

PMID:
12888180
37.

Chronic lithium and sodium valproate both decrease the concentration of myoinositol and increase the concentration of inositol monophosphates in rat brain.

O'Donnell T, Rotzinger S, Nakashima TT, Hanstock CC, Ulrich M, Silverstone PH.

Eur Neuropsychopharmacol. 2003 May;13(3):199-207.

PMID:
12729946
38.

Chronic treatment with lithium, but not sodium valproate, increases cortical N-acetyl-aspartate concentrations in euthymic bipolar patients.

Silverstone PH, Wu RH, O'Donnell T, Ulrich M, Asghar SJ, Hanstock CC.

Int Clin Psychopharmacol. 2003 Mar;18(2):73-9.

PMID:
12598817
39.

Dextro-amphetamine increases phosphoinositol cycle activity in volunteers: an MRS study.

Silverstone PH, O'Donnell T, Ulrich M, Asghar S, Hanstock CC.

Hum Psychopharmacol. 2002 Dec;17(8):425-9.

PMID:
12457379
40.

Chronic treatment with both lithium and sodium valproate may normalize phosphoinositol cycle activity in bipolar patients.

Silverstone PH, Wu RH, O'Donnell T, Ulrich M, Asghar SJ, Hanstock CC.

Hum Psychopharmacol. 2002 Oct;17(7):321-7.

PMID:
12415549
41.

GABA X2 multiplet measured pre- and post-administration of vigabatrin in human brain.

Hanstock CC, Coupland NJ, Allen PS.

Magn Reson Med. 2002 Oct;48(4):617-23.

42.

Reduction in metabolite transverse relaxation times in amyotrophic lateral sclerosis.

Hanstock CC, Cwik VA, Martin WR.

J Neurol Sci. 2002 Jun 15;198(1-2):37-41.

PMID:
12039662
43.

Effects of hyperbaric oxygen on recovery from exercise-induced muscle damage in humans.

Webster AL, Syrotuik DG, Bell GJ, Jones RL, Hanstock CC.

Clin J Sport Med. 2002 May;12(3):139-50.

PMID:
12011721
44.

An (1)H-MRS evaluation of the phosphocreatine/creatine pool (tCr) in human muscle.

Trump ME, Hanstock CC, Allen PS, Gheorghiu D, Hochachka PW.

Am J Physiol Regul Integr Comp Physiol. 2001 Mar;280(3):R889-96.

45.

Proton magnetic resonance spectroscopy (1H-MRS) of the cerebellum in men with schizophrenia.

Tibbo P, Hanstock CC, Asghar S, Silverstone P, Allen PS.

J Psychiatry Neurosci. 2000 Nov;25(5):509-12.

46.

Chronic lithium and sodium valproate both decrease the concentration of myo-inositol and increase the concentration of inositol monophosphates in rat brain.

O'Donnell T, Rotzinger S, Nakashima TT, Hanstock CC, Ulrich M, Silverstone PH.

Brain Res. 2000 Oct 13;880(1-2):84-91.

PMID:
11032992
47.

Effects of lithium and amphetamine on inositol metabolism in the human brain as measured by 1H and 31P MRS.

Silverstone PH, Rotzinger S, Pukhovsky A, Hanstock CC.

Biol Psychiatry. 1999 Dec 15;46(12):1634-41.

PMID:
10624544
48.

Skeletal muscle metabolism during short-term, high-intensity exercise in prepubertal and pubertal girls.

Petersen SR, Gaul CA, Stanton MM, Hanstock CC.

J Appl Physiol (1985). 1999 Dec;87(6):2151-6.

49.

Residual dipolar coupling of the Cr/PCr methyl resonance in resting human medial gastrocnemius muscle.

Hanstock CC, Thompson RB, Trump ME, Gheorghiu D, Hochachka PW, Allen PS.

Magn Reson Med. 1999 Sep;42(3):421-4.

50.

Supplemental Content

Loading ...
Support Center